Building the Future Kadans Science Partner

This special mini series about campus development is part of 'Building the Future'. In this last episode we’ll talk about the future of innovation areas. We take a look at an interesting example: Canary Wharf in East London. Kadans Science Partner and Canary Wharf Group have formed a joint venture to develop a new 750,000 sq ft GIA life-science focused, wet lab-enabled building at Canary Wharf in London. The development will be the first phase in the creation of a world leading centre for health and life sciences on the 3.3 hectare North Quay site next to the new Elizabeth Line underground station. It's slated to turn the once-derelict Docklands into 97 acres of London’s most sought-after office and retail space. 2 guests from the UK discuss the importance of physical interactions and proximity, and ideas regarding future developments of such areas.

Host Rudy van Beurden discusses this topic together with Jinjie Wang (Associate Director Canary Wharf Group), James Sheppard (Managing Director UK & Ireland of Kadans Science Partner) and Paul Jansen (Vice president of IADP).

This special mini series about campus development is part of 'Building the Future'. In this episode we’ll talk about various governance models. We try to find out what model is most successful, using innovation center At the Park in Rijswijk as an example. In addition, we learn why private and commercial investors are crucial for the success of campus development and the importance of strong public and private partnerships.

Host Rudy van Beurden discusses this topic with Armand van de Laar (Alderman at the Municipality of Rijswijk), Jacques van Dinteren (President of IADP) and Michel Leemhuis (CEO of Kadans Science Partner).

This special mini series about campus development is part of 'Building the Future'. In this second episode we’ll talk about the impact of campuses and science parks, focusing on societal and economic impact: why is it important? And what's needed to create impact? How can campus management organizations measure and prove their impact? Campus Groningen is a great example and Edward van der Meer (director of Campus Groningen) will elaborate on their vision and the lessons learned so far.

Edward van der Meer, Jacques van Dinteren (president of IADP) and Tom Straeter (Senior Ecosystem Manager at Kadans) join host Rudy van Beurden at the table.

This special mini series about campus development is part of 'Building the Future'. In this first episode we focus on ecosystems. Specifically, how to build a strong ecosystem. Developing campuses is way more than bricks and mortar: building a strong community requires time and effort from all parties involved. We learn about the different forms and definitions of innovation ecosystems and the value of strong collaborations. We also discuss how Kadans, together with its partners, puts this all into practise in the new Plus Ultra Leiden building at Leiden Bio Science Park.

Host Rudy van Beurden discusses this topic together with 3 guests: Gwen van Overbeke (Governance, Communication & Branding Manager at Leiden Bio Science Park), Paul Jansen (Vice president of IADP) and Tom Straeter (Senior Ecosystem Manager at Kadans).

The search for renewable energy sources is gaining ground. Wind and solar energy have been familiar to us for quite some time, but there are countless other innovations that generate emission-free energy. The question we'll try to answer in this episode is: will we really be able to say goodbye to fossil fuels in the future?

Host Rudy van Beurden has invited three guests who are experts in this field: Johan Knijp, Head of Section Flow and Fuel at DNV, Nick Hol, Head Project Manager of Team Solid and Olaf Adan, CEO of Cellcius.

Do you want to learn more about these speakers or this podcast? Check out kadans.com/podcast

Building the Future is brought to you by Kadans Science Partner.

Cancer is one of the world’s most devastating diseases. Its treatment can be punishing, and have several nasty side effects. Fortunately, scientists have a better idea now of how to treat it, and the experimental techniques being used now may be commonplace in the future. At least, that’s what many experts think.

Host Rudy van Beurden has invited three guests who are experts in this field: Jacqueline Barry, Chief Clinical Officer at CT Catapult; Erik Manting, CEO at Immunicum AB and Trudy Straetemans, Assistant Professor at UMC Utrecht.

Do you want to learn more about these speakers or this podcast? Check out kadans.com/podcast.kadans, cancer, cell therapy, gene therapy, disease, experimental

Building the Future is brought to you by Kadans Science Partner.